Cassandra Vandenberg 34th Lorne Cancer Conference 2022

Abstracts this author is presenting:

• The microtubule inhibitor eribulin demonstrates efficacy in platinum resistant and refractory high-grade serous ovarian cancer patient derived xenograft models — Poster Session 2